New lung cancer screening model removes barriers for central Texas' most vulnerable

byUniversity of Texas at AustinCredit: Pixabay/CC0 Public DomainA new lung cancer screening initiative has made significant strides in overcoming barriers to care for low-income, uninsured and m

Oncology November 09,2024 0

New lung cancer screening model removes barriers for central Texas' most vulnerable

byUniversity of Texas at AustinCredit: Pixabay/CC0 Public DomainA new lung cancer screening initiative has made significant strides in overcoming barriers to care for low-income, uninsured and m

Oncology November 09,2024 0

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Oncology November 09,2024 0

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Oncology November 09,2024 0

How music can help boost cognition in cancer patients and COVID-19 survivors

by Tina Meketa,University of South FloridaCredit: University of South FloridaIn a first-of-its-kind study, University of South Florida researchers are finding that music can help boost cognition

Oncology November 09,2024 0

How music can help boost cognition in cancer patients and COVID-19 survivors

by Tina Meketa,University of South FloridaCredit: University of South FloridaIn a first-of-its-kind study, University of South Florida researchers are finding that music can help boost cognition

Oncology November 09,2024 0

New drug combination offers hope to women with rare treatment-resistant ovarian cancer

byInstitute of Cancer ResearchCredit: Pixabay/CC0 Public DomainA combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ovarian ca

Oncology November 09,2024 0

New drug combination offers hope to women with rare treatment-resistant ovarian cancer

byInstitute of Cancer ResearchCredit: Pixabay/CC0 Public DomainA combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ovarian ca

Oncology November 09,2024 0

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T

Oncology November 09,2024 0

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T

Oncology November 09,2024 0

Scientists glue two proteins together, driving cancer cells to self-destruct

by Rachel Tompa,Stanford University Medical CenterTurning kinase inhibitors into activators of therapeutic genes. Credit:Science(2024). DOI: 10.1126/science.adl5361Our bodies divest

Oncology November 09,2024 0

Scientists glue two proteins together, driving cancer cells to self-destruct

by Rachel Tompa,Stanford University Medical CenterTurning kinase inhibitors into activators of therapeutic genes. Credit:Science(2024). DOI: 10.1126/science.adl5361Our bodies divest

Oncology November 09,2024 0

New CAR-T cells offer on-demand control for cancer treatment

byLudwig Cancer ResearchCredit: Pixabay/CC0 Public DomainLudwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that c

Oncology November 09,2024 0

New CAR-T cells offer on-demand control for cancer treatment

byLudwig Cancer ResearchCredit: Pixabay/CC0 Public DomainLudwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that c

Oncology November 09,2024 0

Researchers unveil inhibition mechanism of receptors on natural killer cells

byUniversity of Science and Technology of ChinaSchematics of GPR34 regulating ILC1 function during tumor progression and suppression. Credit: Prof. Zhou's teamA research team led by Prof. Zh

Oncology November 09,2024 0

Researchers unveil inhibition mechanism of receptors on natural killer cells

byUniversity of Science and Technology of ChinaSchematics of GPR34 regulating ILC1 function during tumor progression and suppression. Credit: Prof. Zhou's teamA research team led by Prof. Zh

Oncology November 09,2024 0

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl

Oncology November 09,2024 0

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl

Oncology November 09,2024 0

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Oncology November 09,2024 0

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Oncology November 09,2024 0